Autopsy report · NCT01244724

Lexapro for Major Depression in Patients With Epilepsy

“Unable to recruit targeted #”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 1 month after it had already started.
• Ran for about 4 years 5 months before it stopped.
• 26 participants enrolled.
• Results were posted on the registry 3 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Weill Medical College of Cornell University

Sponsor type

University, hospital or other

Conditions

Major Depression; Epilepsy

Interventions

Lexapro

Participants

26

Sites

1

Countries

United States

Trials that died the same way

• Comparison of Rectal Trumpet and Standard Care
  “Unable to recruit target enrollment numbers” (79% match in meaning)
• Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway
  “Target recruitment not reached” (76% match in meaning)
• Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis
  “Not able to meet recruitment targets” (75% match in meaning)
• Medication Minimization for Long-term Care Residents
  “unable to recruit” (74% match in meaning)
• Initial Versus Delayed Operation for Treatment of Complicated Appendicitis In Children
  “Unable to adequatly recruit” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.